Vieira Roberto Wandenkolk sold CORT

September 16, 2026 · Form 4 insider transaction

Vieira Roberto Wandenkolk sold 296 shares of Corcept Therapeutics Incorporated at $100.82 per share, a transaction worth $29.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
296
Price
$100.82
Total value
$29.8K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2026
Filing dateSeptember 18, 2026
Shares owned after3,946
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction.; Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 138 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

View the original Form 4 on SEC EDGAR